Skip to main content

Swisher Daniel N JR's Form 4 filing

Corcept Therapeutics Inc (CORT) · filed Sep 6, 2023

Accession no.
0000950170-23-046826
Filed
Sep 6, 2023
Trade date
Sep 1-6, 2023
Filing delay
5 days
Rule 10b5-1 plan
Checked

This filing lists 4 non-derivative transactions and 2 derivative transactions. Open-market sales total $123.1K. It was filed 5 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Swisher Daniel N JRCIK 0001323113Director

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Sep 1, 2023Common StockMOption exerciseAcquired+1,550$6.55+$10,152.51,550Direct
Sep 1, 2023Common StockSSaleDisposed−1,550$32.73−$50,731.50Direct
Sep 5, 2023Common StockMOption exerciseAcquired+2,200$5.86+$12,8922,200Direct
Sep 5, 2023Common StockSSaleDisposed−2,200$32.90−$72,3800Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Sep 1, 2023Common StockMOption exerciseDisposed−1,550$0.00$00Direct
Sep 6, 2023Common StockMOption exerciseDisposed−2,200$0.00$022,150Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

No transaction price on this filing refers to a footnote.

Remarks

The power of attorney under which this form was signed is on file with the Commission.

Read the full filing on SEC EDGAR (opens in a new tab)